NeoGenomics is tapping Warren Stone as CEO effective Jan 4, 2027, with Tony Zook shifting to executive chairman and Lynn Tetrault leaving the board chair. A leadership handoff that distant, alongside

New CEO appointment and preliminary $209M Q3 revenue signal leadership change and growth.